214 related articles for article (PubMed ID: 24789797)
1. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
Gupta PK; Mukherjee P; Dhawan S; Pandey AK; Mazumdar S; Gaur D; Jain SK; Chauhan VS
Clin Vaccine Immunol; 2014 Jun; 21(6):886-97. PubMed ID: 24789797
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
Mazumdar S; Mukherjee P; Yazdani SS; Jain SK; Mohmmed A; Chauhan VS
Infect Immun; 2010 Feb; 78(2):872-83. PubMed ID: 19933832
[TBL] [Abstract][Full Text] [Related]
3. Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35.
Kalra A; Edula JR; Gupta PK; Pandey AK; Chauhan VS
PLoS One; 2016; 11(10):e0165720. PubMed ID: 27798691
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
5. Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.
Mehrizi AA; Rezvani N; Zakeri S; Gholami A; Babaeekhou L
Med Microbiol Immunol; 2018 Apr; 207(2):151-166. PubMed ID: 29397427
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
Sachdeva S; Mohmmed A; Dasaradhi PV; Crabb BS; Katyal A; Malhotra P; Chauhan VS
Vaccine; 2006 Mar; 24(12):2007-16. PubMed ID: 16377036
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of an Optimized
Eacret JS; Parzych EM; Gonzales DM; Burns JM
J Immunol; 2021 Apr; 206(8):1817-1831. PubMed ID: 33789984
[No Abstract] [Full Text] [Related]
8. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
9. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
[TBL] [Abstract][Full Text] [Related]
10. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
12. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
Shi Q; Lynch MM; Romero M; Burns JM
Infect Immun; 2007 Mar; 75(3):1349-58. PubMed ID: 17158895
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
[TBL] [Abstract][Full Text] [Related]
14. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.
Angov E; Aufiero BM; Turgeon AM; Van Handenhove M; Ockenhouse CF; Kester KE; Walsh DS; McBride JS; Dubois MC; Cohen J; Haynes JD; Eckels KH; Heppner DG; Ballou WR; Diggs CL; Lyon JA
Mol Biochem Parasitol; 2003 May; 128(2):195-204. PubMed ID: 12742586
[TBL] [Abstract][Full Text] [Related]
15. Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
Parzych EM; Miura K; Long CA; Burns JM
PLoS One; 2020; 15(4):e0232355. PubMed ID: 32348377
[TBL] [Abstract][Full Text] [Related]
16. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
[TBL] [Abstract][Full Text] [Related]
17. Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
Chitnis CE; Mukherjee P; Mehta S; Yazdani SS; Dhawan S; Shakri AR; Bhardwaj R; Gupta PK; Hans D; Mazumdar S; Singh B; Kumar S; Pandey G; Parulekar V; Imbault N; Shivyogi P; Godbole G; Mohan K; Leroy O; Singh K; Chauhan VS
PLoS One; 2015; 10(4):e0117820. PubMed ID: 25927360
[TBL] [Abstract][Full Text] [Related]
18. Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.
Leung WH; Meng ZQ; Hui G; Ho WK
Biochim Biophys Acta; 2004 Nov; 1675(1-3):62-70. PubMed ID: 15535968
[TBL] [Abstract][Full Text] [Related]
19. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.
Zakeri S; Mehrizi AA; Zoghi S; Djadid ND
Malar J; 2010 Sep; 9():257. PubMed ID: 20846388
[TBL] [Abstract][Full Text] [Related]
20. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.
Faber BW; Remarque EJ; Morgan WD; Kocken CH; Holder AA; Thomas AW
Infect Immun; 2007 Dec; 75(12):5947-55. PubMed ID: 17938224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
